Review



monoclonal mouse anti-human s100 proteins 8b10cc  (HyTest)


Bioz Verified Symbol HyTest is a verified supplier
Bioz Manufacturer Symbol HyTest manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    HyTest monoclonal mouse anti-human s100 proteins 8b10cc
    Monoclonal Mouse Anti Human S100 Proteins 8b10cc, supplied by HyTest, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/monoclonal+mouse+anti+human+s100+proteins/anti+s100+protein++mab+8b10+/pmc10351028-61-25-20
    Average 90 stars, based on 1 article reviews
    monoclonal mouse anti-human s100 proteins 8b10cc - by Bioz Stars, 2026-10
    90/100 stars

    Images

    Related Articles

    Microarray:

    Article Title: A novel point-of-care diagnostic prototype system for the simultaneous electrochemiluminescent sensing of multiple traumatic brain injury biomarkers
    Article Snippet: Antigen S100BB homodimer and S100A1B heterodimer human (ref. 8S9h, HyTest Ltd., Turku, Finland); monoclonal mouse anti-human S100 proteins (ref. 4S37, HyTest Ltd., Turku, Finland) clone 8B10cc and clone 6G1cc were employed as capture and detection antibody, respectively.

    Article Title: Towards a Point-of-Care (POC) Diagnostic Platform for the Multiplex Electrochemiluminescent (ECL) Sensing of Mild Traumatic Brain Injury (mTBI) Biomarkers
    Article Snippet: GFAP assay: Antigen GFAP human recombinant (ref. 8G45, HyTest Ltd., Turku, Finland); monoclonal mouse anti-human glial fibrillary acidic protein (ref. 4G25, HyTest Ltd., Turku, Finland) clone 83cc and clone 81cc were employed as capture and detection antibody, respectively. h-FABP assay: Antigen FABP human (ref. 8F65, HyTest Ltd., Turku, Finland); monoclonal mouse anti-human fatty acid-binding protein (ref. 4F29, HyTest Ltd., Turku, Finland) clone 22 and clone 28cc were employed as capture and detection antibody, respectively.and clone 81cc were employed as capture and detection antibody, respectively. h-FABP assay: Antigen FABP human (ref. 8F65, HyTest Ltd., Turku, Finland); monoclonal mouse anti-human fatty acid-binding protein (ref. 4F29, HyTest Ltd., Turku, Finland) clone 22 and clone 28cc were employed as capture and detection antibody, respectively. ... S100β assay: Antigen S100BB homodimer and S100A1B heterodimer human (ref. 8S9h, HyTest Ltd., Turku, Finland); monoclonal mouse anti-human S100 proteins (ref. 4S37, HyTest Ltd., Turku, Finland) clone 8B10cc and clone 6G1cc were employed as capture and detection antibody, respectively.. Serum samples: Human serum from human male AB plasma, US origin, sterile filtered (ref. H4522, Sigma Aldrich, St. Louis, MO, USA) was diluted 2× with appropriate assay diluents and used for the recovery studies.Serum samples: Human serum from human male AB plasma, US origin, sterile filtered (ref. H4522, Sigma Aldrich, St. Louis, MO, USA) was diluted 2× with appropriate assay diluents and used for the recovery studies.

    Biomarker Discovery:

    Article Title: A novel point-of-care diagnostic prototype system for the simultaneous electrochemiluminescent sensing of multiple traumatic brain injury biomarkers
    Article Snippet: Antigen S100BB homodimer and S100A1B heterodimer human (ref. 8S9h, HyTest Ltd., Turku, Finland); monoclonal mouse anti-human S100 proteins (ref. 4S37, HyTest Ltd., Turku, Finland) clone 8B10cc and clone 6G1cc were employed as capture and detection antibody, respectively.

    Article Title: Towards a Point-of-Care (POC) Diagnostic Platform for the Multiplex Electrochemiluminescent (ECL) Sensing of Mild Traumatic Brain Injury (mTBI) Biomarkers
    Article Snippet: GFAP assay: Antigen GFAP human recombinant (ref. 8G45, HyTest Ltd., Turku, Finland); monoclonal mouse anti-human glial fibrillary acidic protein (ref. 4G25, HyTest Ltd., Turku, Finland) clone 83cc and clone 81cc were employed as capture and detection antibody, respectively. h-FABP assay: Antigen FABP human (ref. 8F65, HyTest Ltd., Turku, Finland); monoclonal mouse anti-human fatty acid-binding protein (ref. 4F29, HyTest Ltd., Turku, Finland) clone 22 and clone 28cc were employed as capture and detection antibody, respectively.and clone 81cc were employed as capture and detection antibody, respectively. h-FABP assay: Antigen FABP human (ref. 8F65, HyTest Ltd., Turku, Finland); monoclonal mouse anti-human fatty acid-binding protein (ref. 4F29, HyTest Ltd., Turku, Finland) clone 22 and clone 28cc were employed as capture and detection antibody, respectively. ... S100β assay: Antigen S100BB homodimer and S100A1B heterodimer human (ref. 8S9h, HyTest Ltd., Turku, Finland); monoclonal mouse anti-human S100 proteins (ref. 4S37, HyTest Ltd., Turku, Finland) clone 8B10cc and clone 6G1cc were employed as capture and detection antibody, respectively.. Serum samples: Human serum from human male AB plasma, US origin, sterile filtered (ref. H4522, Sigma Aldrich, St. Louis, MO, USA) was diluted 2× with appropriate assay diluents and used for the recovery studies.Serum samples: Human serum from human male AB plasma, US origin, sterile filtered (ref. H4522, Sigma Aldrich, St. Louis, MO, USA) was diluted 2× with appropriate assay diluents and used for the recovery studies.

    Control:

    Article Title: A novel point-of-care diagnostic prototype system for the simultaneous electrochemiluminescent sensing of multiple traumatic brain injury biomarkers
    Article Snippet: Antigen S100BB homodimer and S100A1B heterodimer human (ref. 8S9h, HyTest Ltd., Turku, Finland); monoclonal mouse anti-human S100 proteins (ref. 4S37, HyTest Ltd., Turku, Finland) clone 8B10cc and clone 6G1cc were employed as capture and detection antibody, respectively.

    Article Title: Towards a Point-of-Care (POC) Diagnostic Platform for the Multiplex Electrochemiluminescent (ECL) Sensing of Mild Traumatic Brain Injury (mTBI) Biomarkers
    Article Snippet: GFAP assay: Antigen GFAP human recombinant (ref. 8G45, HyTest Ltd., Turku, Finland); monoclonal mouse anti-human glial fibrillary acidic protein (ref. 4G25, HyTest Ltd., Turku, Finland) clone 83cc and clone 81cc were employed as capture and detection antibody, respectively. h-FABP assay: Antigen FABP human (ref. 8F65, HyTest Ltd., Turku, Finland); monoclonal mouse anti-human fatty acid-binding protein (ref. 4F29, HyTest Ltd., Turku, Finland) clone 22 and clone 28cc were employed as capture and detection antibody, respectively.and clone 81cc were employed as capture and detection antibody, respectively. h-FABP assay: Antigen FABP human (ref. 8F65, HyTest Ltd., Turku, Finland); monoclonal mouse anti-human fatty acid-binding protein (ref. 4F29, HyTest Ltd., Turku, Finland) clone 22 and clone 28cc were employed as capture and detection antibody, respectively. ... S100β assay: Antigen S100BB homodimer and S100A1B heterodimer human (ref. 8S9h, HyTest Ltd., Turku, Finland); monoclonal mouse anti-human S100 proteins (ref. 4S37, HyTest Ltd., Turku, Finland) clone 8B10cc and clone 6G1cc were employed as capture and detection antibody, respectively.. Serum samples: Human serum from human male AB plasma, US origin, sterile filtered (ref. H4522, Sigma Aldrich, St. Louis, MO, USA) was diluted 2× with appropriate assay diluents and used for the recovery studies.Serum samples: Human serum from human male AB plasma, US origin, sterile filtered (ref. H4522, Sigma Aldrich, St. Louis, MO, USA) was diluted 2× with appropriate assay diluents and used for the recovery studies.

    Blocking Assay:

    Article Title: A novel point-of-care diagnostic prototype system for the simultaneous electrochemiluminescent sensing of multiple traumatic brain injury biomarkers
    Article Snippet: Antigen S100BB homodimer and S100A1B heterodimer human (ref. 8S9h, HyTest Ltd., Turku, Finland); monoclonal mouse anti-human S100 proteins (ref. 4S37, HyTest Ltd., Turku, Finland) clone 8B10cc and clone 6G1cc were employed as capture and detection antibody, respectively.

    Article Title: Towards a Point-of-Care (POC) Diagnostic Platform for the Multiplex Electrochemiluminescent (ECL) Sensing of Mild Traumatic Brain Injury (mTBI) Biomarkers
    Article Snippet: GFAP assay: Antigen GFAP human recombinant (ref. 8G45, HyTest Ltd., Turku, Finland); monoclonal mouse anti-human glial fibrillary acidic protein (ref. 4G25, HyTest Ltd., Turku, Finland) clone 83cc and clone 81cc were employed as capture and detection antibody, respectively. h-FABP assay: Antigen FABP human (ref. 8F65, HyTest Ltd., Turku, Finland); monoclonal mouse anti-human fatty acid-binding protein (ref. 4F29, HyTest Ltd., Turku, Finland) clone 22 and clone 28cc were employed as capture and detection antibody, respectively.and clone 81cc were employed as capture and detection antibody, respectively. h-FABP assay: Antigen FABP human (ref. 8F65, HyTest Ltd., Turku, Finland); monoclonal mouse anti-human fatty acid-binding protein (ref. 4F29, HyTest Ltd., Turku, Finland) clone 22 and clone 28cc were employed as capture and detection antibody, respectively. ... S100β assay: Antigen S100BB homodimer and S100A1B heterodimer human (ref. 8S9h, HyTest Ltd., Turku, Finland); monoclonal mouse anti-human S100 proteins (ref. 4S37, HyTest Ltd., Turku, Finland) clone 8B10cc and clone 6G1cc were employed as capture and detection antibody, respectively.. Serum samples: Human serum from human male AB plasma, US origin, sterile filtered (ref. H4522, Sigma Aldrich, St. Louis, MO, USA) was diluted 2× with appropriate assay diluents and used for the recovery studies.Serum samples: Human serum from human male AB plasma, US origin, sterile filtered (ref. H4522, Sigma Aldrich, St. Louis, MO, USA) was diluted 2× with appropriate assay diluents and used for the recovery studies.

    Modification:

    Article Title: A novel point-of-care diagnostic prototype system for the simultaneous electrochemiluminescent sensing of multiple traumatic brain injury biomarkers
    Article Snippet: Antigen S100BB homodimer and S100A1B heterodimer human (ref. 8S9h, HyTest Ltd., Turku, Finland); monoclonal mouse anti-human S100 proteins (ref. 4S37, HyTest Ltd., Turku, Finland) clone 8B10cc and clone 6G1cc were employed as capture and detection antibody, respectively.

    Article Title: Towards a Point-of-Care (POC) Diagnostic Platform for the Multiplex Electrochemiluminescent (ECL) Sensing of Mild Traumatic Brain Injury (mTBI) Biomarkers
    Article Snippet: GFAP assay: Antigen GFAP human recombinant (ref. 8G45, HyTest Ltd., Turku, Finland); monoclonal mouse anti-human glial fibrillary acidic protein (ref. 4G25, HyTest Ltd., Turku, Finland) clone 83cc and clone 81cc were employed as capture and detection antibody, respectively. h-FABP assay: Antigen FABP human (ref. 8F65, HyTest Ltd., Turku, Finland); monoclonal mouse anti-human fatty acid-binding protein (ref. 4F29, HyTest Ltd., Turku, Finland) clone 22 and clone 28cc were employed as capture and detection antibody, respectively.and clone 81cc were employed as capture and detection antibody, respectively. h-FABP assay: Antigen FABP human (ref. 8F65, HyTest Ltd., Turku, Finland); monoclonal mouse anti-human fatty acid-binding protein (ref. 4F29, HyTest Ltd., Turku, Finland) clone 22 and clone 28cc were employed as capture and detection antibody, respectively. ... S100β assay: Antigen S100BB homodimer and S100A1B heterodimer human (ref. 8S9h, HyTest Ltd., Turku, Finland); monoclonal mouse anti-human S100 proteins (ref. 4S37, HyTest Ltd., Turku, Finland) clone 8B10cc and clone 6G1cc were employed as capture and detection antibody, respectively.. Serum samples: Human serum from human male AB plasma, US origin, sterile filtered (ref. H4522, Sigma Aldrich, St. Louis, MO, USA) was diluted 2× with appropriate assay diluents and used for the recovery studies.Serum samples: Human serum from human male AB plasma, US origin, sterile filtered (ref. H4522, Sigma Aldrich, St. Louis, MO, USA) was diluted 2× with appropriate assay diluents and used for the recovery studies.

    Plex Assay:

    Article Title: A novel point-of-care diagnostic prototype system for the simultaneous electrochemiluminescent sensing of multiple traumatic brain injury biomarkers
    Article Snippet: Antigen S100BB homodimer and S100A1B heterodimer human (ref. 8S9h, HyTest Ltd., Turku, Finland); monoclonal mouse anti-human S100 proteins (ref. 4S37, HyTest Ltd., Turku, Finland) clone 8B10cc and clone 6G1cc were employed as capture and detection antibody, respectively.

    Article Title: Towards a Point-of-Care (POC) Diagnostic Platform for the Multiplex Electrochemiluminescent (ECL) Sensing of Mild Traumatic Brain Injury (mTBI) Biomarkers
    Article Snippet: GFAP assay: Antigen GFAP human recombinant (ref. 8G45, HyTest Ltd., Turku, Finland); monoclonal mouse anti-human glial fibrillary acidic protein (ref. 4G25, HyTest Ltd., Turku, Finland) clone 83cc and clone 81cc were employed as capture and detection antibody, respectively. h-FABP assay: Antigen FABP human (ref. 8F65, HyTest Ltd., Turku, Finland); monoclonal mouse anti-human fatty acid-binding protein (ref. 4F29, HyTest Ltd., Turku, Finland) clone 22 and clone 28cc were employed as capture and detection antibody, respectively.and clone 81cc were employed as capture and detection antibody, respectively. h-FABP assay: Antigen FABP human (ref. 8F65, HyTest Ltd., Turku, Finland); monoclonal mouse anti-human fatty acid-binding protein (ref. 4F29, HyTest Ltd., Turku, Finland) clone 22 and clone 28cc were employed as capture and detection antibody, respectively. ... S100β assay: Antigen S100BB homodimer and S100A1B heterodimer human (ref. 8S9h, HyTest Ltd., Turku, Finland); monoclonal mouse anti-human S100 proteins (ref. 4S37, HyTest Ltd., Turku, Finland) clone 8B10cc and clone 6G1cc were employed as capture and detection antibody, respectively.. Serum samples: Human serum from human male AB plasma, US origin, sterile filtered (ref. H4522, Sigma Aldrich, St. Louis, MO, USA) was diluted 2× with appropriate assay diluents and used for the recovery studies.Serum samples: Human serum from human male AB plasma, US origin, sterile filtered (ref. H4522, Sigma Aldrich, St. Louis, MO, USA) was diluted 2× with appropriate assay diluents and used for the recovery studies.

    Generated:

    Article Title: A novel point-of-care diagnostic prototype system for the simultaneous electrochemiluminescent sensing of multiple traumatic brain injury biomarkers
    Article Snippet: Antigen S100BB homodimer and S100A1B heterodimer human (ref. 8S9h, HyTest Ltd., Turku, Finland); monoclonal mouse anti-human S100 proteins (ref. 4S37, HyTest Ltd., Turku, Finland) clone 8B10cc and clone 6G1cc were employed as capture and detection antibody, respectively.

    Article Title: Towards a Point-of-Care (POC) Diagnostic Platform for the Multiplex Electrochemiluminescent (ECL) Sensing of Mild Traumatic Brain Injury (mTBI) Biomarkers
    Article Snippet: GFAP assay: Antigen GFAP human recombinant (ref. 8G45, HyTest Ltd., Turku, Finland); monoclonal mouse anti-human glial fibrillary acidic protein (ref. 4G25, HyTest Ltd., Turku, Finland) clone 83cc and clone 81cc were employed as capture and detection antibody, respectively. h-FABP assay: Antigen FABP human (ref. 8F65, HyTest Ltd., Turku, Finland); monoclonal mouse anti-human fatty acid-binding protein (ref. 4F29, HyTest Ltd., Turku, Finland) clone 22 and clone 28cc were employed as capture and detection antibody, respectively.and clone 81cc were employed as capture and detection antibody, respectively. h-FABP assay: Antigen FABP human (ref. 8F65, HyTest Ltd., Turku, Finland); monoclonal mouse anti-human fatty acid-binding protein (ref. 4F29, HyTest Ltd., Turku, Finland) clone 22 and clone 28cc were employed as capture and detection antibody, respectively. ... S100β assay: Antigen S100BB homodimer and S100A1B heterodimer human (ref. 8S9h, HyTest Ltd., Turku, Finland); monoclonal mouse anti-human S100 proteins (ref. 4S37, HyTest Ltd., Turku, Finland) clone 8B10cc and clone 6G1cc were employed as capture and detection antibody, respectively.. Serum samples: Human serum from human male AB plasma, US origin, sterile filtered (ref. H4522, Sigma Aldrich, St. Louis, MO, USA) was diluted 2× with appropriate assay diluents and used for the recovery studies.Serum samples: Human serum from human male AB plasma, US origin, sterile filtered (ref. H4522, Sigma Aldrich, St. Louis, MO, USA) was diluted 2× with appropriate assay diluents and used for the recovery studies.

    Inter Assay:

    Article Title: A novel point-of-care diagnostic prototype system for the simultaneous electrochemiluminescent sensing of multiple traumatic brain injury biomarkers
    Article Snippet: Antigen S100BB homodimer and S100A1B heterodimer human (ref. 8S9h, HyTest Ltd., Turku, Finland); monoclonal mouse anti-human S100 proteins (ref. 4S37, HyTest Ltd., Turku, Finland) clone 8B10cc and clone 6G1cc were employed as capture and detection antibody, respectively.

    Article Title: Towards a Point-of-Care (POC) Diagnostic Platform for the Multiplex Electrochemiluminescent (ECL) Sensing of Mild Traumatic Brain Injury (mTBI) Biomarkers
    Article Snippet: GFAP assay: Antigen GFAP human recombinant (ref. 8G45, HyTest Ltd., Turku, Finland); monoclonal mouse anti-human glial fibrillary acidic protein (ref. 4G25, HyTest Ltd., Turku, Finland) clone 83cc and clone 81cc were employed as capture and detection antibody, respectively. h-FABP assay: Antigen FABP human (ref. 8F65, HyTest Ltd., Turku, Finland); monoclonal mouse anti-human fatty acid-binding protein (ref. 4F29, HyTest Ltd., Turku, Finland) clone 22 and clone 28cc were employed as capture and detection antibody, respectively.and clone 81cc were employed as capture and detection antibody, respectively. h-FABP assay: Antigen FABP human (ref. 8F65, HyTest Ltd., Turku, Finland); monoclonal mouse anti-human fatty acid-binding protein (ref. 4F29, HyTest Ltd., Turku, Finland) clone 22 and clone 28cc were employed as capture and detection antibody, respectively. ... S100β assay: Antigen S100BB homodimer and S100A1B heterodimer human (ref. 8S9h, HyTest Ltd., Turku, Finland); monoclonal mouse anti-human S100 proteins (ref. 4S37, HyTest Ltd., Turku, Finland) clone 8B10cc and clone 6G1cc were employed as capture and detection antibody, respectively.. Serum samples: Human serum from human male AB plasma, US origin, sterile filtered (ref. H4522, Sigma Aldrich, St. Louis, MO, USA) was diluted 2× with appropriate assay diluents and used for the recovery studies.Serum samples: Human serum from human male AB plasma, US origin, sterile filtered (ref. H4522, Sigma Aldrich, St. Louis, MO, USA) was diluted 2× with appropriate assay diluents and used for the recovery studies.

    Concentration Assay:

    Article Title: A novel point-of-care diagnostic prototype system for the simultaneous electrochemiluminescent sensing of multiple traumatic brain injury biomarkers
    Article Snippet: Antigen S100BB homodimer and S100A1B heterodimer human (ref. 8S9h, HyTest Ltd., Turku, Finland); monoclonal mouse anti-human S100 proteins (ref. 4S37, HyTest Ltd., Turku, Finland) clone 8B10cc and clone 6G1cc were employed as capture and detection antibody, respectively.

    Article Title: Towards a Point-of-Care (POC) Diagnostic Platform for the Multiplex Electrochemiluminescent (ECL) Sensing of Mild Traumatic Brain Injury (mTBI) Biomarkers
    Article Snippet: GFAP assay: Antigen GFAP human recombinant (ref. 8G45, HyTest Ltd., Turku, Finland); monoclonal mouse anti-human glial fibrillary acidic protein (ref. 4G25, HyTest Ltd., Turku, Finland) clone 83cc and clone 81cc were employed as capture and detection antibody, respectively. h-FABP assay: Antigen FABP human (ref. 8F65, HyTest Ltd., Turku, Finland); monoclonal mouse anti-human fatty acid-binding protein (ref. 4F29, HyTest Ltd., Turku, Finland) clone 22 and clone 28cc were employed as capture and detection antibody, respectively.and clone 81cc were employed as capture and detection antibody, respectively. h-FABP assay: Antigen FABP human (ref. 8F65, HyTest Ltd., Turku, Finland); monoclonal mouse anti-human fatty acid-binding protein (ref. 4F29, HyTest Ltd., Turku, Finland) clone 22 and clone 28cc were employed as capture and detection antibody, respectively. ... S100β assay: Antigen S100BB homodimer and S100A1B heterodimer human (ref. 8S9h, HyTest Ltd., Turku, Finland); monoclonal mouse anti-human S100 proteins (ref. 4S37, HyTest Ltd., Turku, Finland) clone 8B10cc and clone 6G1cc were employed as capture and detection antibody, respectively.. Serum samples: Human serum from human male AB plasma, US origin, sterile filtered (ref. H4522, Sigma Aldrich, St. Louis, MO, USA) was diluted 2× with appropriate assay diluents and used for the recovery studies.Serum samples: Human serum from human male AB plasma, US origin, sterile filtered (ref. H4522, Sigma Aldrich, St. Louis, MO, USA) was diluted 2× with appropriate assay diluents and used for the recovery studies.

    Binding Assay:

    Article Title: A novel point-of-care diagnostic prototype system for the simultaneous electrochemiluminescent sensing of multiple traumatic brain injury biomarkers
    Article Snippet: Antigen S100BB homodimer and S100A1B heterodimer human (ref. 8S9h, HyTest Ltd., Turku, Finland); monoclonal mouse anti-human S100 proteins (ref. 4S37, HyTest Ltd., Turku, Finland) clone 8B10cc and clone 6G1cc were employed as capture and detection antibody, respectively.

    Article Title: Towards a Point-of-Care (POC) Diagnostic Platform for the Multiplex Electrochemiluminescent (ECL) Sensing of Mild Traumatic Brain Injury (mTBI) Biomarkers
    Article Snippet: GFAP assay: Antigen GFAP human recombinant (ref. 8G45, HyTest Ltd., Turku, Finland); monoclonal mouse anti-human glial fibrillary acidic protein (ref. 4G25, HyTest Ltd., Turku, Finland) clone 83cc and clone 81cc were employed as capture and detection antibody, respectively. h-FABP assay: Antigen FABP human (ref. 8F65, HyTest Ltd., Turku, Finland); monoclonal mouse anti-human fatty acid-binding protein (ref. 4F29, HyTest Ltd., Turku, Finland) clone 22 and clone 28cc were employed as capture and detection antibody, respectively.and clone 81cc were employed as capture and detection antibody, respectively. h-FABP assay: Antigen FABP human (ref. 8F65, HyTest Ltd., Turku, Finland); monoclonal mouse anti-human fatty acid-binding protein (ref. 4F29, HyTest Ltd., Turku, Finland) clone 22 and clone 28cc were employed as capture and detection antibody, respectively. ... S100β assay: Antigen S100BB homodimer and S100A1B heterodimer human (ref. 8S9h, HyTest Ltd., Turku, Finland); monoclonal mouse anti-human S100 proteins (ref. 4S37, HyTest Ltd., Turku, Finland) clone 8B10cc and clone 6G1cc were employed as capture and detection antibody, respectively.. Serum samples: Human serum from human male AB plasma, US origin, sterile filtered (ref. H4522, Sigma Aldrich, St. Louis, MO, USA) was diluted 2× with appropriate assay diluents and used for the recovery studies.Serum samples: Human serum from human male AB plasma, US origin, sterile filtered (ref. H4522, Sigma Aldrich, St. Louis, MO, USA) was diluted 2× with appropriate assay diluents and used for the recovery studies.

    Multiplex Assay:

    Article Title: A novel point-of-care diagnostic prototype system for the simultaneous electrochemiluminescent sensing of multiple traumatic brain injury biomarkers
    Article Snippet: Antigen S100BB homodimer and S100A1B heterodimer human (ref. 8S9h, HyTest Ltd., Turku, Finland); monoclonal mouse anti-human S100 proteins (ref. 4S37, HyTest Ltd., Turku, Finland) clone 8B10cc and clone 6G1cc were employed as capture and detection antibody, respectively.

    Article Title: Towards a Point-of-Care (POC) Diagnostic Platform for the Multiplex Electrochemiluminescent (ECL) Sensing of Mild Traumatic Brain Injury (mTBI) Biomarkers
    Article Snippet: GFAP assay: Antigen GFAP human recombinant (ref. 8G45, HyTest Ltd., Turku, Finland); monoclonal mouse anti-human glial fibrillary acidic protein (ref. 4G25, HyTest Ltd., Turku, Finland) clone 83cc and clone 81cc were employed as capture and detection antibody, respectively. h-FABP assay: Antigen FABP human (ref. 8F65, HyTest Ltd., Turku, Finland); monoclonal mouse anti-human fatty acid-binding protein (ref. 4F29, HyTest Ltd., Turku, Finland) clone 22 and clone 28cc were employed as capture and detection antibody, respectively.and clone 81cc were employed as capture and detection antibody, respectively. h-FABP assay: Antigen FABP human (ref. 8F65, HyTest Ltd., Turku, Finland); monoclonal mouse anti-human fatty acid-binding protein (ref. 4F29, HyTest Ltd., Turku, Finland) clone 22 and clone 28cc were employed as capture and detection antibody, respectively. ... S100β assay: Antigen S100BB homodimer and S100A1B heterodimer human (ref. 8S9h, HyTest Ltd., Turku, Finland); monoclonal mouse anti-human S100 proteins (ref. 4S37, HyTest Ltd., Turku, Finland) clone 8B10cc and clone 6G1cc were employed as capture and detection antibody, respectively.. Serum samples: Human serum from human male AB plasma, US origin, sterile filtered (ref. H4522, Sigma Aldrich, St. Louis, MO, USA) was diluted 2× with appropriate assay diluents and used for the recovery studies.Serum samples: Human serum from human male AB plasma, US origin, sterile filtered (ref. H4522, Sigma Aldrich, St. Louis, MO, USA) was diluted 2× with appropriate assay diluents and used for the recovery studies.

    Diagnostic Assay:

    Article Title: A novel point-of-care diagnostic prototype system for the simultaneous electrochemiluminescent sensing of multiple traumatic brain injury biomarkers
    Article Snippet: Antigen S100BB homodimer and S100A1B heterodimer human (ref. 8S9h, HyTest Ltd., Turku, Finland); monoclonal mouse anti-human S100 proteins (ref. 4S37, HyTest Ltd., Turku, Finland) clone 8B10cc and clone 6G1cc were employed as capture and detection antibody, respectively.

    Article Title: Towards a Point-of-Care (POC) Diagnostic Platform for the Multiplex Electrochemiluminescent (ECL) Sensing of Mild Traumatic Brain Injury (mTBI) Biomarkers
    Article Snippet: GFAP assay: Antigen GFAP human recombinant (ref. 8G45, HyTest Ltd., Turku, Finland); monoclonal mouse anti-human glial fibrillary acidic protein (ref. 4G25, HyTest Ltd., Turku, Finland) clone 83cc and clone 81cc were employed as capture and detection antibody, respectively. h-FABP assay: Antigen FABP human (ref. 8F65, HyTest Ltd., Turku, Finland); monoclonal mouse anti-human fatty acid-binding protein (ref. 4F29, HyTest Ltd., Turku, Finland) clone 22 and clone 28cc were employed as capture and detection antibody, respectively.and clone 81cc were employed as capture and detection antibody, respectively. h-FABP assay: Antigen FABP human (ref. 8F65, HyTest Ltd., Turku, Finland); monoclonal mouse anti-human fatty acid-binding protein (ref. 4F29, HyTest Ltd., Turku, Finland) clone 22 and clone 28cc were employed as capture and detection antibody, respectively. ... S100β assay: Antigen S100BB homodimer and S100A1B heterodimer human (ref. 8S9h, HyTest Ltd., Turku, Finland); monoclonal mouse anti-human S100 proteins (ref. 4S37, HyTest Ltd., Turku, Finland) clone 8B10cc and clone 6G1cc were employed as capture and detection antibody, respectively.. Serum samples: Human serum from human male AB plasma, US origin, sterile filtered (ref. H4522, Sigma Aldrich, St. Louis, MO, USA) was diluted 2× with appropriate assay diluents and used for the recovery studies.Serum samples: Human serum from human male AB plasma, US origin, sterile filtered (ref. H4522, Sigma Aldrich, St. Louis, MO, USA) was diluted 2× with appropriate assay diluents and used for the recovery studies.

    Standard Deviation:

    Article Title: A novel point-of-care diagnostic prototype system for the simultaneous electrochemiluminescent sensing of multiple traumatic brain injury biomarkers
    Article Snippet: Antigen S100BB homodimer and S100A1B heterodimer human (ref. 8S9h, HyTest Ltd., Turku, Finland); monoclonal mouse anti-human S100 proteins (ref. 4S37, HyTest Ltd., Turku, Finland) clone 8B10cc and clone 6G1cc were employed as capture and detection antibody, respectively.

    Article Title: Towards a Point-of-Care (POC) Diagnostic Platform for the Multiplex Electrochemiluminescent (ECL) Sensing of Mild Traumatic Brain Injury (mTBI) Biomarkers
    Article Snippet: GFAP assay: Antigen GFAP human recombinant (ref. 8G45, HyTest Ltd., Turku, Finland); monoclonal mouse anti-human glial fibrillary acidic protein (ref. 4G25, HyTest Ltd., Turku, Finland) clone 83cc and clone 81cc were employed as capture and detection antibody, respectively. h-FABP assay: Antigen FABP human (ref. 8F65, HyTest Ltd., Turku, Finland); monoclonal mouse anti-human fatty acid-binding protein (ref. 4F29, HyTest Ltd., Turku, Finland) clone 22 and clone 28cc were employed as capture and detection antibody, respectively.and clone 81cc were employed as capture and detection antibody, respectively. h-FABP assay: Antigen FABP human (ref. 8F65, HyTest Ltd., Turku, Finland); monoclonal mouse anti-human fatty acid-binding protein (ref. 4F29, HyTest Ltd., Turku, Finland) clone 22 and clone 28cc were employed as capture and detection antibody, respectively. ... S100β assay: Antigen S100BB homodimer and S100A1B heterodimer human (ref. 8S9h, HyTest Ltd., Turku, Finland); monoclonal mouse anti-human S100 proteins (ref. 4S37, HyTest Ltd., Turku, Finland) clone 8B10cc and clone 6G1cc were employed as capture and detection antibody, respectively.. Serum samples: Human serum from human male AB plasma, US origin, sterile filtered (ref. H4522, Sigma Aldrich, St. Louis, MO, USA) was diluted 2× with appropriate assay diluents and used for the recovery studies.Serum samples: Human serum from human male AB plasma, US origin, sterile filtered (ref. H4522, Sigma Aldrich, St. Louis, MO, USA) was diluted 2× with appropriate assay diluents and used for the recovery studies.



    Similar Products

    monoclonal mouse anti-human s100 proteins 8b10cc  (HyTest)
    90
    HyTest monoclonal mouse anti-human s100 proteins 8b10cc
    Monoclonal Mouse Anti Human S100 Proteins 8b10cc, supplied by HyTest, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/monoclonal+mouse+anti+human+s100+proteins/anti+s100+protein++mab+8b10+/pmc10351028-61-25-20
    Average 90 stars, based on 1 article reviews
    monoclonal mouse anti-human s100 proteins 8b10cc - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier
    monoclonal mouse anti human s100 proteins  (HyTest)
    96
    HyTest monoclonal mouse anti human s100 proteins
    Microarray-type SR-ECLIA 3-plex protocol: a) schematic representation of the assay established for detection of three mTBI biomarkers (GFAP, h-FABP, <t>S100β)</t> on a single SPCE. STEP 1 includes the spotting of small quantities of capture antibodies of each biomarker on the predefined spot positions on the SPCE using a spotter device (BSA labelled with SULFO-TAG was used for control/alignment purposes); STEP 2 includes the typical sandwich assay protocol composed of a blocking step, addition of three antigens, and addition of detection antibodies modified with the SULFO-TAG label carrying Ru(bpy) 3 2+ ; STEP 3 is the detection step that includes addition of the tripropylamine (TPA) co-reactant and applying a potential on the SPCE to trigger the ECL signal generation from each biomarker spot; STEP 4 comprises the raw data processing; b) optimization of capture antibody amount per spot (cAb amount for all biomarkers: 7.00 ng per spot, 2.10 ng per spot, 0.70 ng per spot, 0.18 ng per spot). The antigen concentrations were 0, 1, 10 and 50 ng mL −1 . The other assay conditions are listed in SI-5.
    Monoclonal Mouse Anti Human S100 Proteins, supplied by HyTest, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/monoclonal+mouse+anti+human+s100+proteins/S100%2C+bb%2Bab/pmc10351028-61-13-20
    Average 96 stars, based on 1 article reviews
    monoclonal mouse anti human s100 proteins - by Bioz Stars, 2026-10
    96/100 stars
    		  Buy from Supplier
    mouse monoclonal anti-human s100 protein  (Agilent technologies)
    90
    Agilent technologies mouse monoclonal anti-human s100 protein
    Microarray-type SR-ECLIA 3-plex protocol: a) schematic representation of the assay established for detection of three mTBI biomarkers (GFAP, h-FABP, <t>S100β)</t> on a single SPCE. STEP 1 includes the spotting of small quantities of capture antibodies of each biomarker on the predefined spot positions on the SPCE using a spotter device (BSA labelled with SULFO-TAG was used for control/alignment purposes); STEP 2 includes the typical sandwich assay protocol composed of a blocking step, addition of three antigens, and addition of detection antibodies modified with the SULFO-TAG label carrying Ru(bpy) 3 2+ ; STEP 3 is the detection step that includes addition of the tripropylamine (TPA) co-reactant and applying a potential on the SPCE to trigger the ECL signal generation from each biomarker spot; STEP 4 comprises the raw data processing; b) optimization of capture antibody amount per spot (cAb amount for all biomarkers: 7.00 ng per spot, 2.10 ng per spot, 0.70 ng per spot, 0.18 ng per spot). The antigen concentrations were 0, 1, 10 and 50 ng mL −1 . The other assay conditions are listed in SI-5.
    Mouse Monoclonal Anti Human S100 Protein, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/monoclonal+mouse+anti+human+s100+proteins/pm36693547-77-19-25
    Average 90 stars, based on 1 article reviews
    mouse monoclonal anti-human s100 protein - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier
    anti human s100b monoclonal antibody  (Bio-Rad)
    90
    Bio-Rad anti human s100b monoclonal antibody
    Microarray-type SR-ECLIA 3-plex protocol: a) schematic representation of the assay established for detection of three mTBI biomarkers (GFAP, h-FABP, <t>S100β)</t> on a single SPCE. STEP 1 includes the spotting of small quantities of capture antibodies of each biomarker on the predefined spot positions on the SPCE using a spotter device (BSA labelled with SULFO-TAG was used for control/alignment purposes); STEP 2 includes the typical sandwich assay protocol composed of a blocking step, addition of three antigens, and addition of detection antibodies modified with the SULFO-TAG label carrying Ru(bpy) 3 2+ ; STEP 3 is the detection step that includes addition of the tripropylamine (TPA) co-reactant and applying a potential on the SPCE to trigger the ECL signal generation from each biomarker spot; STEP 4 comprises the raw data processing; b) optimization of capture antibody amount per spot (cAb amount for all biomarkers: 7.00 ng per spot, 2.10 ng per spot, 0.70 ng per spot, 0.18 ng per spot). The antigen concentrations were 0, 1, 10 and 50 ng mL −1 . The other assay conditions are listed in SI-5.
    Anti Human S100b Monoclonal Antibody, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/monoclonal+mouse+anti+human+s100+proteins/Mouse+anti+Human+S100+Protein/10__1016_slash_j__snb__2019__126652-78-21-31
    Average 90 stars, based on 1 article reviews
    anti human s100b monoclonal antibody - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Microarray-type SR-ECLIA 3-plex protocol: a) schematic representation of the assay established for detection of three mTBI biomarkers (GFAP, h-FABP, S100β) on a single SPCE. STEP 1 includes the spotting of small quantities of capture antibodies of each biomarker on the predefined spot positions on the SPCE using a spotter device (BSA labelled with SULFO-TAG was used for control/alignment purposes); STEP 2 includes the typical sandwich assay protocol composed of a blocking step, addition of three antigens, and addition of detection antibodies modified with the SULFO-TAG label carrying Ru(bpy) 3 2+ ; STEP 3 is the detection step that includes addition of the tripropylamine (TPA) co-reactant and applying a potential on the SPCE to trigger the ECL signal generation from each biomarker spot; STEP 4 comprises the raw data processing; b) optimization of capture antibody amount per spot (cAb amount for all biomarkers: 7.00 ng per spot, 2.10 ng per spot, 0.70 ng per spot, 0.18 ng per spot). The antigen concentrations were 0, 1, 10 and 50 ng mL −1 . The other assay conditions are listed in SI-5.

    Journal: Sensors & Diagnostics

    Article Title: A novel point-of-care diagnostic prototype system for the simultaneous electrochemiluminescent sensing of multiple traumatic brain injury biomarkers †

    doi: 10.1039/d3sd00090g

    Figure Lengend Snippet: Microarray-type SR-ECLIA 3-plex protocol: a) schematic representation of the assay established for detection of three mTBI biomarkers (GFAP, h-FABP, S100β) on a single SPCE. STEP 1 includes the spotting of small quantities of capture antibodies of each biomarker on the predefined spot positions on the SPCE using a spotter device (BSA labelled with SULFO-TAG was used for control/alignment purposes); STEP 2 includes the typical sandwich assay protocol composed of a blocking step, addition of three antigens, and addition of detection antibodies modified with the SULFO-TAG label carrying Ru(bpy) 3 2+ ; STEP 3 is the detection step that includes addition of the tripropylamine (TPA) co-reactant and applying a potential on the SPCE to trigger the ECL signal generation from each biomarker spot; STEP 4 comprises the raw data processing; b) optimization of capture antibody amount per spot (cAb amount for all biomarkers: 7.00 ng per spot, 2.10 ng per spot, 0.70 ng per spot, 0.18 ng per spot). The antigen concentrations were 0, 1, 10 and 50 ng mL −1 . The other assay conditions are listed in SI-5.

    Article Snippet: Antigen S100BB homodimer and S100A1B heterodimer human (ref. 8S9h, HyTest Ltd., Turku, Finland); monoclonal mouse anti-human S100 proteins (ref. 4S37, HyTest Ltd., Turku, Finland) clone 8B10cc and clone 6G1cc were employed as capture and detection antibody, respectively.

    Techniques: Microarray, Biomarker Discovery, Control, Blocking Assay, Modification

    Microarray-type SR-ECLIA 3-plex assay performance in 50% serum (v/v) using POC prototype detection system: a) capture antibody spotting pattern (letter “C” – BSA@SULFO-TAG control spots; letter “G” – GFAP biomarker spots; letter “H” – h-FABP biomarker spots; letter “S” – S100β biomarker spots); and corresponding ECL raw data images generated at various biomarker concentrations (0, 250, 500, 750, and 1000 pg mL −1 ) (8 × 8 binning and dark subtraction, but no other postprocessing), and b) obtained 3-plex calibration curves. The error bars represent the standard deviations from two replicates ( n = 2) and the fitting was performed with a 4-PL equation; c) assay specificity heatmap at single antigen concentrations of 2.5 ng mL −1 .

    Journal: Sensors & Diagnostics

    Article Title: A novel point-of-care diagnostic prototype system for the simultaneous electrochemiluminescent sensing of multiple traumatic brain injury biomarkers †

    doi: 10.1039/d3sd00090g

    Figure Lengend Snippet: Microarray-type SR-ECLIA 3-plex assay performance in 50% serum (v/v) using POC prototype detection system: a) capture antibody spotting pattern (letter “C” – BSA@SULFO-TAG control spots; letter “G” – GFAP biomarker spots; letter “H” – h-FABP biomarker spots; letter “S” – S100β biomarker spots); and corresponding ECL raw data images generated at various biomarker concentrations (0, 250, 500, 750, and 1000 pg mL −1 ) (8 × 8 binning and dark subtraction, but no other postprocessing), and b) obtained 3-plex calibration curves. The error bars represent the standard deviations from two replicates ( n = 2) and the fitting was performed with a 4-PL equation; c) assay specificity heatmap at single antigen concentrations of 2.5 ng mL −1 .

    Article Snippet: Antigen S100BB homodimer and S100A1B heterodimer human (ref. 8S9h, HyTest Ltd., Turku, Finland); monoclonal mouse anti-human S100 proteins (ref. 4S37, HyTest Ltd., Turku, Finland) clone 8B10cc and clone 6G1cc were employed as capture and detection antibody, respectively.

    Techniques: Microarray, Plex Assay, Control, Biomarker Discovery, Generated

    Results of the inter-assay variability (CV) for the 3-plex SR-ECLIA for three independent experiments made in duplicate measurements. Preliminary recovery results for the mTBI biomarkers with 50% human serum (v/v) in assay diluent spiked at 800 pg mL −1 . The calculations were made with calibration curves generated in complex matrix

    Journal: Sensors & Diagnostics

    Article Title: A novel point-of-care diagnostic prototype system for the simultaneous electrochemiluminescent sensing of multiple traumatic brain injury biomarkers †

    doi: 10.1039/d3sd00090g

    Figure Lengend Snippet: Results of the inter-assay variability (CV) for the 3-plex SR-ECLIA for three independent experiments made in duplicate measurements. Preliminary recovery results for the mTBI biomarkers with 50% human serum (v/v) in assay diluent spiked at 800 pg mL −1 . The calculations were made with calibration curves generated in complex matrix

    Article Snippet: Antigen S100BB homodimer and S100A1B heterodimer human (ref. 8S9h, HyTest Ltd., Turku, Finland); monoclonal mouse anti-human S100 proteins (ref. 4S37, HyTest Ltd., Turku, Finland) clone 8B10cc and clone 6G1cc were employed as capture and detection antibody, respectively.

    Techniques: Inter Assay, Generated, Concentration Assay